Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ Dengue Virus Type 2/4 Envelope Recombinant Rabbit Monoclonal Antibody (HL2089)

Rabbit Recombinant Monoclonal Antibody

Supplier:  Invitrogen™ MA550377

Catalog No. FEMA550377


Only null left
Add to Cart

Description

Description

Dengue Virus Type 2/4 Envelope Recombinant Monoclonal Antibody for Western Blot, ICC/IF

The Dengue Virus Type 2/4 Envelope gene is a target for research and development of vaccines and therapies for the Dengue virus. Dengue fever is a mosquito-borne viral disease that is prevalent in tropical and subtropical regions around the world. The virus has four serotypes, and infection with one serotype does not provide immunity against the others. The Envelope gene is responsible for encoding the structural protein that forms the outer shell of the virus, which plays a crucial role in the virus's entry into host cells and subsequent replication.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Dengue Virus Type 2/4 Envelope
Recombinant Monoclonal
1 mg/mL
PBS with no preservative
Rabbit
Protein A
RUO
Virus
Antibody
IgG
Western Blot, Immunocytochemistry
HL2089
Unconjugated
DENV Type 2/3 Envelope
Recombinant fragment of Dengue virus Envelope protein.
100 μL
Primary
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.